Comera Life Sciences Holdings Cash Flow Statement 2020-2025 | CMRA

Fifteen years of historical annual cash flow statements for Comera Life Sciences Holdings (CMRA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202220212020
$-18.00$-5.45$-3.28
$0.09$0.09$0
$5.59$1.03$3.07
$5.68$1.12$3.07
$-0.03$0.11$0
$0$0$0
$0.86$0.32$0
$0.93$-0.25$-0.33
$2.55$0.57$-0.18
$-9.77$-3.76$-0.39
$-0.03$-0.14$0
$0$0$0
$0$0$0
$0$0$0
$0$0$-107.09
$0$0$-107.09
$0$0$0
$-0.03$-0.14$-107.09
$0$0.75$0
$0$0$0
$0$0.75$0
$1.49$0.18$109
$1.49$9.53$109
$0$0$0
$3.75$0$-0.55
$5.24$10.28$108
$-4.56$6.38$0.99
$0.38$1.11$0
$0$0$0